全文获取类型
收费全文 | 3226899篇 |
免费 | 266239篇 |
国内免费 | 13504篇 |
专业分类
耳鼻咽喉 | 44398篇 |
儿科学 | 96641篇 |
妇产科学 | 80915篇 |
基础医学 | 517989篇 |
口腔科学 | 88622篇 |
临床医学 | 287378篇 |
内科学 | 564405篇 |
皮肤病学 | 86889篇 |
神经病学 | 276062篇 |
特种医学 | 126875篇 |
外国民族医学 | 105篇 |
外科学 | 510935篇 |
综合类 | 96152篇 |
现状与发展 | 23篇 |
一般理论 | 2156篇 |
预防医学 | 264159篇 |
眼科学 | 73712篇 |
药学 | 223699篇 |
24篇 | |
中国医学 | 9533篇 |
肿瘤学 | 155970篇 |
出版年
2021年 | 54624篇 |
2020年 | 34832篇 |
2019年 | 57771篇 |
2018年 | 70272篇 |
2017年 | 53509篇 |
2016年 | 58984篇 |
2015年 | 73460篇 |
2014年 | 107566篇 |
2013年 | 172594篇 |
2012年 | 83181篇 |
2011年 | 81364篇 |
2010年 | 113844篇 |
2009年 | 119209篇 |
2008年 | 69682篇 |
2007年 | 71130篇 |
2006年 | 82770篇 |
2005年 | 78128篇 |
2004年 | 80249篇 |
2003年 | 71455篇 |
2002年 | 61595篇 |
2001年 | 102523篇 |
2000年 | 95462篇 |
1999年 | 95520篇 |
1998年 | 64407篇 |
1997年 | 62403篇 |
1996年 | 60152篇 |
1995年 | 55637篇 |
1994年 | 49630篇 |
1993年 | 46399篇 |
1992年 | 66314篇 |
1991年 | 62643篇 |
1990年 | 59163篇 |
1989年 | 58736篇 |
1988年 | 54178篇 |
1987年 | 52895篇 |
1986年 | 49821篇 |
1985年 | 50256篇 |
1984年 | 45932篇 |
1983年 | 42323篇 |
1982年 | 40527篇 |
1981年 | 38220篇 |
1980年 | 35945篇 |
1979年 | 36894篇 |
1978年 | 33046篇 |
1977年 | 30818篇 |
1976年 | 27616篇 |
1975年 | 26182篇 |
1974年 | 26561篇 |
1973年 | 25228篇 |
1972年 | 23721篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems 总被引:1,自引:0,他引:1
Using cortical cups in chloralose-urethanized rats, the in vivo release of cholecystokinin-like immunoreactivity (CCK-LI) from cerebral cortex was examined. Resting levels of cholecystokinin-like immunoreactivity ranged from 20 to 30 pg/20 min sample. The addition of potassium (40 mM) in excess, resulted in a highly significant elevation in the levels of CCK-LI in the cortical superfusate. Deletion of calcium and the substitution of cobalt (10 mM), resulted in a significant reduction in both resting release and the release otherwise evoked by the addition of potassium. Focal electrical stimulation of the cortex (20 Hz), resulted in a significant (1.9 +/- 0.2-fold, n = 8) increase in the levels of CCK-LI. The addition of glutamate (10(-6)-10(-4) M) of kainic acid (10(-8)-10(-6) M), also resulted in significant elevations in the levels of CCK-LI. The co-administration of a putative glutamate receptor antagonist, kynurenic acid (10(-4) M) resulted in a significant reduction in the levels of release otherwise evoked by the addition of glutamate, but not by electrical stimulation. The addition of GABA (10(-5)-10(-3) M) resulted in a dose-dependent decrease in the resting release of CCK-LI, and the release evoked by glutamate. Picrotoxin (10(-6)-10(-4) M), resulted in a highly significant increase in the levels of CCK-LI in the cortical effluent. These results are consistent with a tonic GABAergic inhibition of CCK-releasing neurons. The treatment of the animal with diazepam (30 mg/kg, i.p.) also resulted in a significant reduction in resting release and the release otherwise evoked by focal cortical stimulation. 相似文献
992.
C.T. PEASE M. FENNELL R.C.D. STAUGHTON D.A. BREWERTON 《The British journal of dermatology》1987,117(2):161-167
Polymorphonuclear leukocyte (PMN) migration was assessed in vitro using the agarose plate method in patients with psoriasis vulgaris, and compared with an age- and sex-matched control group. No significant difference was found between the two groups in the PMN response to the chemotactic substances F-Met-Leu-Phe (FMLP) or zymosan activated serum (ZAS). Equally, the chemokinetic or chemotactic potential of psoriatic serum did not differ from control serum. Our results do not support a primary abnormality of PMN function in psoriasis. 相似文献
993.
994.
995.
S B Wieslander B T Mortensen L Binderup N I Nissen 《European journal of haematology》1987,39(1):35-38
10 patients with CLL and 2 with CML were treated with gradually increasing doses of 1 alpha(OH)D3, up to 4 micrograms daily during 6 wk. 3 patients with preleukemia and 1 with myelofibrosis were treated with 2 micrograms daily of 1 alpha(OH)D3 for a prolonged period up to 17 wk. The treatment with 1 alpha (OH)D3 did not result in changes of disease parameters in any of the patients under study. Receptor studies for 1,25(OH)2D3 were performed in 8 CLL patients and revealed only 1 patient with increased specific receptor binding capacity. The maximum tolerable dose of 1 alpha(OH)D3 varied individually, but was in the range of 2-4 micrograms daily. 相似文献
996.
997.
IgG-maleimide peroxidase, Fab'-maleimide peroxidase, polymer and monomer types of Fab'-periodate peroxidase were prepared from an antibody against rat lipoamide dehydrogenase, a component of the pyruvate dehydrogenase complex which is located in mitochondria. They were examined for immunohistochemical staining of the rat kidney. Fab'-maleimide peroxidase was the best for staining mitochondrial protein. IgG-maleimide peroxidase and the monomer type of Fab'-periodate peroxidase had the same intensity of staining. The polymer type of Fab'-periodate peroxidase could not stain the lipoamide dehydrogenase. 相似文献
998.
999.
1000.